Tyra Biosciences Inc. (TYRA)
$26.64
$-0.54
(-1.99%)
As on 05-Jun-2026 16:00EDT
Market cap
$1,584 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
4.2
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.4 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-7
-
Debt to Equity
0
-
Book Value
$4.8
-
EPS
$-2.2
-
Face value
--
-
Shares outstanding
59,470,381
5 Years Aggregate
CFO
$-134.55 Mln
EBITDA
$-176.76 Mln
Net Profit
$-160.37 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Tyra Biosciences (TYRA)
| 1.3 | -24.2 | -24.5 | 159.6 | 22.4 | -- | -- |
|
BSE Sensex
| -12.3 | -3.9 | -6.2 | -8.3 | 5.9 | 7.3 | 10.7 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
Tyra Biosciences (TYRA)
| 89.1 | 0.4 | 82.2 | -46.0 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Tyra Biosciences (TYRA)
|
26.6 | 1,584.3 | 0.0 | -131.1 | -- | -39.2 | -- | 4.2 |
| 73.1 | 10,295.2 | 622.0 | -300.9 | -25.7 | -61.1 | -- | 16.8 | |
| 71.5 | 9,704.9 | 105.8 | -829.6 | -715.0 | -- | -- | 60.5 | |
| 52.7 | 13,246.4 | 2,375.5 | 833.4 | 40.8 | 40.7 | 17.5 | 6.8 | |
| 71.5 | 8,484.4 | 1,508.5 | 348.8 | 57.0 | 96.4 | 25.1 | 38.6 | |
| 301.0 | 8,873.4 | 417.3 | 225.0 | 42.8 | 18.6 | 40.3 | 6.9 | |
| 487.0 | 11,227.7 | 1,132.5 | -309.4 | -25.5 | -52.9 | -- | 20.9 | |
| 454.3 | 12,973.2 | 2,678.3 | 460.4 | 21.1 | 103.2 | 28.6 | 21.9 | |
| 91.0 | 7,184.9 | 0.0 | -450.1 | -- | -44.6 | -- | 6.3 | |
| 254.0 | 7,081.2 | 0.0 | -326.5 | -- | -37.2 | -- | 5.2 |
Shareholding Pattern
View DetailsAbout Tyra Biosciences (TYRA)
Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a precision medicine platform that enables drug design... through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions. Its lead product candidate is FGFR3, which is in clinical trials for the treatment of patients with metastatic urothelial carcinoma and other solid tumors. The company is also developing TYRA-300 for skeletal conditions, including achondroplasia, hypochondroplasia, dysplasia, and other FGFR3-driven genetic syndromes; TYRA-200, a candidate in clinical trial for intrahepatic cholangiocarcinoma; and TYRA-430 for the treatment of hepatocellular carcinoma. Tyra Biosciences, Inc. was incorporated in 2018 and is headquartered in Carlsbad, California. Read more
-
Co-Founder, President, CEO, Secretary, Treasurer & Director
Dr. Todd Harris Ph.D.
-
Co-Founder, President, CEO, Secretary, Treasurer & Director
Dr. Todd Harris Ph.D.
-
Headquarters
Carlsbad, CA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Tyra Biosciences (TYRA)
What is the current share price of Tyra Biosciences Inc (TYRA) Today?
The share price of Tyra Biosciences Inc (TYRA) is $26.64 (NASDAQ) as of 05-Jun-2026 16:00 EDT. Tyra Biosciences Inc (TYRA) has given a return of 22.39% in the last 3 years.
What is the current PB & PE ratio of Tyra Biosciences Inc (TYRA)?
Since, TTM earnings of Tyra Biosciences Inc (TYRA) is negative, P/E ratio is not available.
The P/B ratio of Tyra Biosciences Inc (TYRA) is 4.17 times as on 05-Jun-2026, a 2 premium to its peers’ median range of 4.07 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-13.15
|
6.09
|
|
2024
|
-9.16
|
2.31
|
|
2023
|
-8.61
|
2.92
|
|
2022
|
-6.17
|
1.24
|
|
2021
|
-7.54
|
0.65
|
What is the 52 Week High and Low of Tyra Biosciences Inc (TYRA)?
The 52-week high and low of Tyra Biosciences Inc (TYRA) are Rs 40.65 and Rs 8.98 as of 08-Jun-2026.
What is the market cap of Tyra Biosciences Inc (TYRA)?
Tyra Biosciences Inc (TYRA) has a market capitalisation of $ 1,584 Mln as on 05-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Tyra Biosciences Inc (TYRA)?
Before investing in Tyra Biosciences Inc (TYRA), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.